期刊
JOURNAL OF BIOTECHNOLOGY
卷 259, 期 -, 页码 204-212出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jbiotec.2017.07.008
关键词
NphB; THCA synthase; CBGA; THCA; Saccharomyces cerevisiae; Komagataella phaffii
资金
- Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW)
- TU Dortmund University through a scholarship from the CUB-Graduate Cluster Industrial Biotechnology (CLIB)
Delta(9)-tetrahydrocannabinolic acid (THCA) is a plant derived secondary natural product from the plant Cannabis sativa L. The discovery of the human endocannabinoid system in the late 1980s resulted in a growing number of known physiological functions of both synthetic and plant derived cannabinoids. Thus, manifold therapeutic indications of cannabinoids currently comprise a significant area of research. Here we reconstituted the final biosynthetic cannabinoid pathway in yeasts. The use of the soluble prenyltransferase NphB from Streptomyces sp. strain CL190 enables the replacement of the native transmembrane prenyltransferase cannabigerolic acid synthase from C. sativa. In addition to the desired product cannabigerolic acid, NphB catalyzes an O-prenylation leading to 2-0-geranyl olivetolic acid. We show for the first time that the bacterial prenyltransferase and the final enzyme of the cannabinoid pathway tetrahydrocannabinolic acid synthase can both be actively expressed in the yeasts Saccharomyces cerevisiae and Komagataella phaffii simultaneously. While enzyme activities in S. cerevisiae were insufficient to produce THCA from olivetolic acid and geranyl diphosphate, genomic multi-copy integrations of the enzyme's coding sequences in K. phaffii resulted in successful synthesis of THCA from olivetolic add and geranyl diphosphate. This study is an important step toward total biosynthesis of valuable cannabinoids and derivatives and demonstrates the potential for developing a sustainable and secure yeast bio-manufacturing platform.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据